Find the latest Avenue Therapeutics, Inc. ATXI analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Analyst Price Targets 8.00 ...

Access NASDAQ:ATXI financials, view the annual report and financial statements, including income statement, balance sheet, cash flow. Investing.com - Financial Markets Worldwide Open in App ...

One stock that might be an intriguing choice for investors right now is Avenue Therapeutics, Inc. ATXI. This is because this security in the Medical – Drugs space is seeing solid earnings ...

ATXI Avenue Therapeutics Inc. $0.2409-42.6 % BBLG Bone Biologics Corp. ... gaining 17% to $0.6370 after JonesTrading initiated coverage on the stock with a Buy rating and $5 price target.

NEW YORK, Dec. 12, 2021 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market ...